Table 4 Comparison of baseline characteristics in patients with HT after IVT
Variables | mRS 0–2 (342) | mRS 3–6 (639) | p Value |
|---|---|---|---|
Age (year) | 73 (64–79) | 80 (72–85) |  < 0.001 |
Male, % | 222 (64.9) | 346 (54.1) | 0.001 |
Medical history | |||
 Hypertension, % | 224 (65.5) | 439 (68.7) | 0.317 |
 Diabetes mellitus, % | 51 (14.9) | 106 (16.6) | 0.523 |
 Hypercholesterolemia, % | 12 (3.5) | 40 (6.3) | 0.073 |
 Atrial fibrillation, % | 83 (24.3) | 248 (38.8) |  < 0.001 |
 Previous ischemic stroke, % | 28 (8.2) | 111 (17.4) |  < 0.001 |
 Smoking, % | 80 (23.4) | 115 (18.0) | 0.045 |
Prior drugs use | |||
 Prior antiplatelet use, % | 53 (15.5) | 133 (20.8) | 0.049 |
 Prior anticoagulant use, % | 4 (1.2) | 22 (3.4) | 0.037 |
 Prior statin use, % | 30 (8.8) | 67 (10.5) | 0.433 |
Baseline systolic pressure (mmHg) | 156 (140–169) | 160 (143–172) | 0.026 |
Baseline diastolic pressure (mmHg) | 87 (77–96) | 86 (78–95) | 0.620 |
Baseline NIHSS score | 6 (3–11) | 14 (10–20) |  < 0.001 |
OTT (min) | 115 (110–209) | 157 (113–206) | 0.570 |
Remote hemorrhage | 116 (33.9) | 296 (46.3) |  < 0.001 |
Fibrinolytic drug | Â | Â | 0.677 |
 rt-PA, % | 339 (99.1) | 630 (98.6) |  |
 Urokinase, % | 3 (0.9) | 9 (1.4) |  |
Hemorrhage type |  |  |  < 0.001 |
 HI, % | 255 (74.6) | 286 (44.8) |  |
 PH, % | 87 (25.4) | 353 (55.2) |  |